---
document_datetime: 2025-02-05 11:26:04
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vabysmo-epar-all-authorised-presentations_en.pdf
document_name: vabysmo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7667318
conversion_datetime: 2025-12-24 21:47:56.859982
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                       |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|---------------------------------|
| EU/1/22/1683/001 | Vabysmo           | 120 mg/ml  | Solution for injection | Intravitreal use          | vial (glass)               | 0.24 ml                   | 1 vial + 1 needle               |
| EU/1/22/1683/002 | Vabysmo           | 120 mg/ml  | Solution for injection | Intravitreal use          | pre-filled syringe (glass) | 0.175 ml                  | 1 pre-filled syringe + 1 needle |